Table 4.
Change in IGF-1, baseline to 12-month follow-up
| Placebo (n = 21) | Atorvastatin (n = 20) | ||
|---|---|---|---|
| Mean change (95% CI) | Mean change (95% CI) | P value | |
| IGF-1 (ng/mL) | −3.3 (−14.7–8.2) | 14.7 (2.4–27.0) | 0.0308 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.